Traumesektoren varetager behandlingen af akut traumatologi på over- og underekstremiteter og varetager det daglige ansvar for behandlingen af svært tilskadekomne, som bringes ind via traumecenteret. 

Traumesektoren råder over et dagligt operationsleje til akut traumatologi, samt tværfagligt over sengeafsnit.

Der er etableret et tværfagligt samarbejde med geriatrisk team, som vurderer og behandler patienterne medicinsk, og står for overflytning til genoptræningspladser. 

Traumesektoren har en stab på 5 overlæger samt 3 afdelingslæger.

Overekstremiteter

Alle almindeligt forekommende brud og læsioner på overekstremiteten. Desuden komplekse brudtyper eventuelt i samarbejde med skulder/albuesektoren.

For eksempel:

• Osteosyntese af frakturer af dislocerede frakturer af cavitas glenoidalis foretages på Arhus Universitetshospital.
• Osteosyntese af dislocerede laterale og midskaftsfrakturer foretages på Aarhus Universitetshospital
• Flerfragment frakturer af proximale humerus foretages på Aarhus Universitetshospital.
• Osteosyntese af dislocerede supra og intracondylære distale humerusfrakturer foretages på Aarhus Universitetshospital.
• Behandling af alle typer underarmsfrakturer foretages på Aarhus Universitetshospital.
• Behandling af komplekse håndlæsioner varetages på Aarhus Universitetshospital
• Flerseneskader behandles på Aarhus Universitetshospital..

Underekstremiteten

På Aarhus Universitetshospital behandles alle almindeligt forekommende brud og læsioner på underekstremiteten.

• Patologiske frakturer af lange rørknogler behandles på Aarhus Universitetshospital. Efterkontrollen varetages af tumorsektoren.
• Lukkede skaftfrakturer af femur og tibia behandles primært med marvsømning.
• Børnefemurfrakturer behandles på Aarhus Universitetshospital.
• Efterbehandlingen varetages af børnesektoren.
• Supra og intracondylære femurfrakturer behandles ofte med retrograd femurmarvsømning.
• Tibiacondylfrakturer behandles på Aarhus Universitethospital
• Flerligamentskader og ACL skader i knæet behandles primært konservativt og viderevisiteres herefter til videre behandling i idrætssektoren på Aarhus Universitetshospital.
• Komplekse læsioner i mellem og bagfod som kræver operativ behandling varetages af overlæge Kjeld Andersen ofte i samarbejde med fod –ankelsektoren på Aarhus Universitetshospital.

Sektorchef, Overlæge, Ph.d.

Jeppe Barckmann

Afdelingssygeplejerske

Pernille Didriksen (SA3)

Overlæge 

Kjeld Andersen
E-mail: kjeld.andersen@aarhus.rm.dk

Overlæge

Lars Borris
E-mail: larsborr@rm.dk

Overlæge, Ph.d., MPA
Ole Brink
email: olebrink@rm.dk

Overlæge
Klaus Kjær Petersen

Den daglige ledelse og kontaktpersoner i enheden er

Overlæge Lars Borris
Traumesektoren, Ortopædkirurgisk Afdeling E
Aarhus Universitetshospital 
Telefon: 7846 4513
Email: larsborr@rm.dk   

Overlæge Ole Brink 
Traumesektoren, Ortopædkirurgisk Afdeling E
Aarhus Universitetshospital
Telefon: 7846 4540
Email: olebrink@rm.dk

Faergemann C, Lauritsen JM, Brink O, Mortensen PB. Do repeat victims of interpersonal violence have different demographic and socioeconomic characters from non-repeat victims of interpersonal violence and the general population? A population-bases case-control study. Scand J Public Health.  Scand J Public Health. 2010; 38(5):524-532.

Thorninger R, Borris LC, Brink O. Coagulation activity in elderly patients measured by prothrombin fragment 1+2 in urine. Clinical and Applied Thrombosis/Hemostasis. Accepted 05-08-2010.

Brink O, Borris LC, Hougaard K. Effective treatment at a Danish trauma center. Danish Medical Bulletin. Accepted 04-01-2012.

Brink O, Borris LC. (forfatter til kap. 9). Getting your research paper published. A surgical perspective. Stuttgart 2011. ThiemeVerlag. ISBN 978-3-13-149991-2

Brink O, Borris LC (forfatter til kap 56). Evidence-Based Orthopedics. West Sussex 2012. Wiley-Blackwell. ISBN 978-1-4051-8476-21.

Rohde MC, Charles AV, Banner J, Brink O.
Rape and attempted rape in Aarhus County, Denmark. Police reported and unreported cases. Forensic Sci Med Pathol. 2006;2:33-48.

Faergemann C, Lauritsen JM, Brink O, Skov O.
Trends in deliberate interpersonal violence in the Odense Municipality, Denmark 1991-2002. J Clin Forensic Med. 2007;14:20-26.

Faergemann C, Lauritsen JM, Brink O, Stovring H.
What is the lifetime risk of contact with an A&E department or an Institute of Forensic Medicine following violent victimization? Injury. 2008; 39:121-7. Epub 2006 Sep 1.

Faergemann C, Lauritsen JM, Brink O, Stovring H.
The epidemiology of repeat contacts with an A&E department or an Institute of Forensic Medicine due to violent victimization in a Danish urban population. J Clin Forensic Med. 2007; 14: 333-339

Faergemann C, Lauritsen JM, Brink O, Skov O.
Development in violence in Odense City from 1991-2002. Ugeskr Laeger. 2007:169(26)2532-2535.

Mikkelsen S, Frandsen H, Vesterby A, Brink O.
Who seeks testing for sexually transferred diseases (STD) after sexual assault ? Scandinavian Journal of Forensic Sciences 2006: 84-87.

Bhandari M, Sprague S, Tornetta P, D´Aurora V, Schemitsch E, Shearer H, Brink O, Mathews D & Dosanjh S. (Mis)Perceptions about intimate partner violence in women presenting to orthopaedic care: A survey of Canadian orthopaedic surgeons. JBJS Am. 2008 Jul;90(7):1590-7.

Zlowodzki M, Brink O, Switzer J, Wingerter S, Woodall J, Petrisor B, Kregor PJ, Bruinsma DR, Bhandari M.
Patient function following femoral neck shortening after screw fixation of femoral neck fractures. JBJS (Br) 2008; 90(11):1487-1494.

Brink O. When violence strikes the head, neck and face. Journal of Trauma. 2009; 67(1):147-151.

Hansen OI, Sabroe S, Brink O, Knudsen M, Charles AV.
Characteristics of victims and assaults of sexual violence –improving inquiries and prevention. Journal of Forensic & Legal Medicine. 2009;16(4):182-188.

Hansens OI, Brink O, Sabroe S, Sørensen V, Charles AV.
Legal aspects of sexual violence –does forensic evidence makes a difference? Forensic Sci Int. 2008 Sep 1. Forensic Sci Int. 2008; 180(2-3): 98-104.

Ole Brink: Masterafhandling (MPA):
Når organisationen svigter og forsinker operationen. Antaget ved det Samfundsvidenskabelige Fakultet, Aalborg Universitet den 22.01.2008.

Faergemann C, Lauritsen JM, Brink O, Skov O, Mortensen PB.
Demographic and socioeconomic risk factors of adult violent victimization from an accident and emergency department and forensic medicine perspective: A register-based case-control study. J Forensic Leg Med. 2009 Jan;16(1):11-7. Epub 2008 Aug 12.

Hansen OI, Elklit A, Sabroe S, Charles AV, Brink O.
Sexual Assault-Induced Sequelae: Posttraumatic Stress Disorder and Presence of Pain. Scandinavian Journal of Forensic Science 2008;14(2):54-58.

Hansen OI, Brink O, Sabroe S, Sørensen V, Charles AV.
Retsligt udfald af voldtægtssager –Har de retsmedicinske fund en betydning? Nordisk Tidsskrift for Kriminalvidenskab 2009; 96(3):277-286.

Brink O, Borris LC, Andersen K, Hougaard K.
Orams tegn på hofte- eller bækkenlidelse. Ugeskr Læger 2009;171(51):3760-3763.

Olsen J, Gundgaard J, Borris L.
Omkostningseffektivitet ved venøs tromboseprofylakse med fondaparinux sammenlignet med enoxaparin i Danmark. (The cost-effectiveness of fondaparinux compared to enoxaparin as prophylaxis for deep-vein thrombosis in Denmark). Ugeskr. Laeger 2005; 167: 2273-9.

Eriksson BI, Borris L, Dahl OE, Haas S, Huisman MV, Kakkar AK, Misselwitz F, Kälebo P.
Oral, direct Factor Xa inhibition with BAY 59-7939 for the prevention of venous thromboembolism after total hip replacement. J Thromb Haemost 2006; 4: 121-8.

Eriksson BI, Borris LC, Dahl OE, Haas S, Huisman MV, Kakkar AK, Muehlhofer E, Dierig C, Misselwitz F, Kälebo P for the ODIXa-HIP Study Investigators. A once-daily, oral, direct factor Xa inhibitor, rivaroxaban (BAY 59-7939), for thromboprophylaxis after total hip replacement. Circulation 2006; 114:2374-81.

Fisher WD, Eriksson BI, Bauer KA, Borris L, et al.
Rivaroxaban for thromboprophylaxis after orthopaedic surgery: pooled analysis of two studies. Thromb Haemost 2007; 97: 931-7.

Eriksson BI, Borris LC, Dahl OE, Haas S, Huisman MV, Kakkar AK, Misselwitz F, Muelhofer E, Kälebo P.
Dose-escalation study of rivaroxaban (BAY 59-7939) – an oral, direct Factor Xa inhibitor – for the prevention of venous thromboembolism in patients undergoing total hip replacement. Thromb Res 2007; 120: 685-93.

Borris LC, Breindahl M, Ryge C, Sommer HM, Lassen MR. The uF1+2 Study Group.
Prothrombin fragment 1+2 in urine as an indicator of sustained coagulation activation after total hip arthroplasty.  Thromb Res 2007; 121:369-76.

Dahl OE, Borris LC, Bergqvist D, Schnack Rasmussen M et al.
Major joint replacement. A model for  antithrombotic drug development:: from proof-of-concept to clinical use. Int Angiol 2008; 27: 60-7.

Mueck W, Eriksson BI, Bauer KA, Borris L et al.
Population pharmakokinetics and pharmacodynamics of rivaroxaban – an oral, direct Factor Xa inhibitor – in patients undergoing major orthopaedic surgery. Clin Pharmacokinet 2008;47:203-16.

Eriksson BI, Borris LC, Friedman RJ, Haas S, Huisman MV, Kakkar AK, Bandel TJ, Beckmann H, Muehlhofer E, Misselwitz F, Geerts W for the RECORD1 investigators. Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty. N Engl J Med 2008; 358: 2765-75.

Lassen MR, Ageno W, Borris LC, Lieberman JR, Rosencher N, Bandel TJ, Misselwitz F, Turpie AGG for the RECORD3 investigators. Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty. N Engl J Med 2008; 358: 2776-86.

Mueck W, Borris LC, Haas S, Huisman MV, Kakkar AK, Kälebo P, Muelhofer E, et al.
Population pharmocokinetics and pharmacodynamics of once- and twice-daily rivaroxaban for the prevention of  venous thromboembolism in patients undergoing total hip replacement. Thromb Haemost 2008; 100: 453-61.

Borris LC, Breindahl M, Lassen MR, Pap AF, Misselwitz F.
Differences in urinary prothrombin fragment 1+2 levels after total hip replacement in relation to venous thromboembolism and bleeding events. J Thromb Haemost 2008; 6: 1671- 9.

Borris LC.
New compounds in the management of venous thromboembolism after orthopaedic surgery; focus on Rivaroxaban. Vasc Health Risk Manag 2008; 4: 855-62.

Borris LC.
Behandling af collum femoris frakturer i Danmark (Treatment of femoral neck fractures in Denmark) editorial. Ugeskr. Læger 2008; 170: 2947.

Borris LC.
Barriers to the optimal use of anticoagulants after orthopaedic surgery. Arch Orthop Trauma Surg 2009; 129: 1441-5.

32.Borris LC.
Rivaroxaban, a new, oral, direct Factor Xa inhibitor for thromboprophylaxis after major joint arthroplasty. Expert Opin Pharmacother 2009; 10: 1083-8.

33. Borris LC.
Rivaroxaban and dabigatran etexilate: two new oral anticoagulants for extended postoperative prevention of venous thromboembolism after elective total hip arthroplasty. Arch Orthop Trauma Surg 2010; 130; 583-9.

Lassen MR, Raskob GE, Gallus A et al. (Borris LC)
Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial. Lancet 2010; 375: 807-15.

Borris LC.
Venous thromboembolic disease after total hip arthroplasty. Minerva Orthop & Traumatol (in press).

Borris LC.
Emerging antithrombotic agents for thromboprophylaxis; clinical potential and patient considerations. J Blood Med (in press).

Borris L.
Protrombin koncentrationen i urin som indikator for koagulationsaktivering (1). DSTH Forum 2006; 4: 9-14.

Borris LC.
Nye antitrombotika på vej. Hospital Health Care 2008; 12(3): 12-18.Borris LC.

Borris LC.
Nye antitrombotika til profylakse. DSTH Forum 2008; 3: 14-22.

Borris L.
Protrombin fragment 1+2 koncentrationen i urin som indikator for koagulationsaktivering (2). DSTH Forum 2009; 1: 15-17.

Borris LC.
Rivaroxaban: a new oral factor Xa inhibitor anticoagulant. Hospital Pharmacy Europe 2009; 42.

Hansen OI, Brink O, Knudsen M, Elklit A, Vesterby A.
Presentation of the Aarhus County Sexual Assault Center. Rechtsmedizin. 2005; 281.

1. Bhandari M, Sprague S, Schemitsch EH, International Hip Fracture Research Collaborative. J Orthop Trauma. 2009;23(6):479-84.

2. Karanicolas PJ, Bhandari M, Kreder H, Moroni A, Richardson M, Walter SD, Norman GR, Guyatt GH; Collaboration for Outcome Assessment in Surgical Trials (COAST) Muscoloskeletal Group. J Bone Joint Surg Am. 2009; 91 Suppl 3:99-106.

3. Karanicolas PJ, Bhandari M, Walter SD, Heels-Ansdell D, Guyatt GH; Collaboration for Outcome Assessment in Surgical Trials (COAST) Musculoskeletal Group. Radiographs of hip fracture were digitally altered to mask surgeons to the type of implant without compromising the reliability of quality ratings or making the rating process more difficult. J Clin Epidemiology 2009;62(2):214-223.

4. PRAISE Investigators, Bhandari M, Sprague S, Dosanjh S, Wu V, Schemitsch EH. Prevalence of Abuse and Intimate Partner Violence Surgical Evaluation (P.R.A.I.S.E.): rationale and design of a multi-center cross-sectional study. BMC Musculosklet Disorder. 2010 APR 23;11:77

5. Ingemann-Hansen O, Brink O. Sexual victimization and legal outcome by documentation of sperm and alcohol. Inj Prev 2010 16: A177.

6. Andersen TE, Elklit A, Brink O. PTSD Symptoms mediate the effect of attachment on pain and somatisation after whiplash injury. Clin Pract Epidemiol Ment Health. 2013 May 17;9:75-83.

7. PRAISE Investigators. Prevalence of abuse and intimate partner violence surgical evaluation (PRAISE) in orthopaedic fracture clinics: a multinational prevalence study. Lancet. 2013 Jun 11. Epub ahead of print.

8. Heiselberg SE, Brink O. Alvorlige knoglebrud efter leg på Segway-køretøj. Ugeskr Læger 2013, oktober 7 (epub ahead of print).

9. Van Kollenburg JA, Vrahas MS, Smith RM, Guitton TG, Ring D; Science of Variation Group. Diagnosis of union of distal tibia fractures: accuracy and interobserver reliability. Injury 2013 Aug;44(8):1073-5.

1. Færgemann C, Lauritsen JM, Brink O, Skov O, Mortensen PB. The risk of violent victimization in adults in relation to socioeconomic and demographic factors. A register-base matched case-control study. 8^th World Conference on Injury Prevention and Safety Promotion, Durban 2006.

2. Færgemann C, Lauritsen JM, Brink O, Skov O, Mortensen PB. The risk of violent victimization in adults in relation to socioeconomic and demographic factors. A register-base matched case-control study. 8^th World Conference on Injury Prevention and Safety Promotion, Durban 2006.

3. Hansen OI, Vesterby A, Brink O, Knudsen M. The Western Danish Sexual Assault Center. 8^th World Conference on Injury Prevention and Safety Promotion, Durban 2006.

4. Lorentzen ND, Vester AE, Brink O, Hougaard K. Traumatic aortic rupture: Initial priorities and treatment. Dos forårsmøde, Aarhus 2007.

5. Zlowodzki M, Brink O, Switzer J, Wingerter S, Woodall J, Petrisor B, Kregor PJ, Bruinsma DR, Bhandari M. Patient function following femoral neck shortening and varus collapse after cancellous screw fixation of isolated femoral neck fractures: A multicenter cohort study. Orthopaedic Trauma Association, 23^rd Annual Meeting. Boston, MA, October 17-20, 2007

6. Andreassen G, Brink O, Kurkinen M, Kainonen T. Healing of ankle fractures: Comparison of biodegradable and metal plate and screws. AAOS (American Academy of Orthopaedic Surgeons) 75 th annual meeting, San Francisco. 2008

7. Zlowodzki M, Brink O, Switzer J, Wingerter S, Woodall J, Petrisor B, Kregor PJ, Bruinsma DR, Bhandari M. Patient function following femoral neck shortening after screw fixation of femoral neck fractures. OTA Specialty day – Top 10 Presentation from 2007 OTA meeting. San Francisco, CA.

8. Zlowodzki M, Brink O, Switzer J, Wingerter S, Woodall J, Petrisor B, Kregor PJ, Bruinsma DR, Bhandari M. Patient function following femoral neck shortening after screw fixation of femoral neck fractures. American Academy of Ortopaedic Surgeons, 75^th Annual Meeting. San Francisco, CA, March 8-11, 2008.

9. Zlowodzki M, Brink O, Switzer J, Wingerter S, Woodall J, Petrisor B, Kregor PJ, Bruinsma DR, Bhandari M. Patient function following femoral neck shortening after screw fixation of femoral neck fractures. 63^d Canadian Orthopaedic Association Annual Meeting, Quebec City, Canada, June 4-7, 2008.

10. Bhandari M, Sprague S, Dáurora V, Shearer H, Brink O, Mathews D, Dosanjh S.  (Mis)Perceptions about intimate partner violence among orthopaedic surgeons. 63^d Canadian Orthopaedic Association Annual Meeting  Quebec City, Canada, June 4-7, 2008.

11. Zlowodzki M, Brink O, Switzer J, Wingerter S, Woodall J, Petrisor B, Kregor PJ, Bruinsma DR, Bhandari M. Patient function following femoral neck shortening after screw fixation of femoral neck fractures. 9th European Congress for Emergency and Trauma Surgery. Budapest, Hungary, May 24-27, 2008.

12. Brink O, Zlowodzki M, Switzer J, Wingerter S, Woodall J, Petrisor B, Kregor PJ, Bruinsma DR, Bhandari M. Patient function following femoral neck shortening after screw fixation of femoral neck fractures. Dansk Ortopædisk Selskab efterårsmøde, København, 2008.

13. Hansen, O.I., Brink, O., Sabroe, S., Sørensen, V., Elklit, A., Vesterby, A. 2008, "Legal and health consequences of sexual violence in Aarhus",  The First International Conference on Survivors of Rape - a Multidisciplinary Approach. Århus, 2008.

14. Dos forårsmøde, Odense 2009. Brink O, Hougaard K, Borris LC. Continuous training of all members of a trauma team organization results in a faster initial evaluation and treatment of trauma patients.

15. Dos årsmøde, København 2009. Thorninger R, Borris LC, Brink O. Coagulation activity in elderly patients with fracture of the hip based on measurements of prothrombin fragment 1+2 in urine.

16. Canadian Orthopaedic Association Annual Meeting, Edmonton, AB.  June, 2010. Bhandari M, Bojan A, Ekholm C, Brink O, Joensson A. Functional outcomes following intramedullary nailing of throchanteric hip fractures: A pilot multicenter, randomized controlled trial.

17. NOF, Aarhus 2010. Brink O, Hougaard K, Borris LC. Continuous training of all members of a trauma team organization results in a faster initial evaluation and treatment of trauma patients.

18. NOF, Aarhus 2010. Bhandari M, Bojan A, Ekholm C, Brink O, Joensson A. Functional outcomes following intramedullary nailing of throchanteric hip fractures: A pilot multicenter, randomized controlled trial.

19. NOF, Aarhus 2010. Thorninger R, Borris LC, Brink O. Coagulation activity in elderly patients with fracture of the hip based on measurements of prothrombin fragment 1+2 in urine.

Kristensen H, Brink O, Thorninger R, Borris L, Andersen K. Risk factors for lag-screw cut-out in intertrochanteric fractures. 12 th EFORT Congress, Copenhagen 1-4 June 2011.

Kristensen H, Brink O, Thorninger R, Borris L, Andersen K. Risk factors for lag-screw cut-out in intertrochanteric fractures. SICOT Congress, Prague September 2011.

Inviterede foredrag

1. The Principles and Practice of clinical Research. AIOD Clinical research Group. Trauma Care Institute Nice, Frankrig. (Medlem af fakultetet) 04-06.01.2006.

2. Principles and Practice of clinical Research. How to Design, Analyze, and Participate in Orthopaedic Trauma Research. Göteborg, Sverige. (Medlem af fakultetet). 23-25-04.2007. Arangeret af OTC, Clinical Research Group.

3. The Principles and Practice of clinical Research. Amsterdam, Holland (Medlem af fakultetet) 16-18.04.2008.

4. The Principles and Practice of clinical Research. Göteborg, Sverige (Medlem af fakultetet) 16-18.04.2008.

5. Frakturdagarna. Arrangeret af Sahlgrenska Universitetssjukhuset og Göteborgs Universitet. Göteborg, Sverige. 18-20.04.2008.

6. Hip fractures – Advances in treatment and an Evidence Bases Approach. Arrangeret af OTC. 7-9.11.2008 Nice.

7. The Principles and Practice of clinical Research. Athen. Arrangeret af OTC Hellas. (Medlem af fakultetet) 28-03-2009.

1. Jensen LT, Brink O, Borris L, Heslop J. Postoperative analgesia for pertrochanteric fracture of the hip. DOS forårsmøde 2008, Aalborg.

2. Zlowodzki M, Brink O, Switzer J, Wingerter S, Woodall J, Petrisor B, Kregor PJ, Bruinsma DR, Bhandari M. Patient function following femoral neck shortening after screw fixation of femoral neck fractures. European Federation of National Associations of Orthopaedics and Traumatology (EFORT), 9th annual Meeting. Nice, France, May 29 – June 1, 2008.

3. Bhandari M, Sprague S, Dáurora V, Shearer H, Brink O, Mathews D, Dosanjh S. (Mis)Perceptions about intimate partner violence among orthopaedics surgeons. European Federation of National Associations of Orthopaedics and Traumatology (EFORT), 9th annual Meeting. Nice, France, May 29 – June 1, 2008.

Medarrangør af og underviser på kursus i ”tromboseprofylakse for sygeplejersker”, Middelfart, oktober 2005.

Trauma Research Unit), Aarhus Universitetshospital 

Godkendt ved det første bestyrelsesmøde den 20. december, 2005

§1: Traumatologisk Forskningsenhed, Aarhus Universitetshospital har til formål:

• at drive klinisk forskning indenfor relevante områder.
• at have ansvaret for databaser (traumedatabase og frakturdatabase).
• at drive voldsforskning herunder føre relevante registre
• at fremme uddannelsen indenfor alle aspekter af Ortopædisk Traumatologi.

§2: Bestyrelsen består af de til enhver tid fastansatte speciallæger i Traumesektoren, Ortopædkirurgisk afd. E, den lægelige leder af Skadesektoren, Aarhus Universitetshospital, Afdelingsledelsen afd. E, samt den ansvarlige fagprofessor.

Formand for bestyrelsen udnævnes på 1. ordinære bestyrelsesmøde, samtidig besluttes det, hvor lang tid formandskabet kan vare.

§3: Den daglige ledelse består af 2 overlæger ansat i Traumesektoren, udpeges af bestyrelsen med overordnet ansvar for forskningsaktiviteterne i enheden. De har også ansvar for ansættelse af fornødent personale til den daglige drift.
Ansvaret for de enkelte projekter uddelegeres til de ansvarlige, som initierer projekterne.

§4: Bestyrelsen holder ordinært møde en gang årligt. Meddelelse om tid og sted samt dagsorden skal tilstilles medlemmerne senest 14 dage forud for mødet. Bestyrelsen kan mødes hyppigere, hvis der er flertal for det.

§5: Alle der ønsker at forske i enhedens regi skal forpligtes til at indbetale min.10% af et evt. overskud til enhedens konto.
Enheden skal økonomisk hvile i sig selv, idet de midler som projekterne indbringer bruges til lønninger til projektpersonalet. Et eventuelt overskud bruges til at initiere nye projekter, dække udgifter i forbindelse med rejser og møder, betale kongres gebyrer, udgifter til præsentationer (postere o.l.).

§6: Regnskabet skal føres i overensstemmelse med sygehusets gældende regler for forskningsmidler. Regnskabsåret følger kalenderåret. Regnskabet skal forelægges til godkendelse ved det årlige ordinære bestyrelsesmøde.

§7: Forskningsprojekter kan initieres af Forskningsenhedens læger eller være projekter, der kommer udefra. De indsamlede data tilhører enheden med mindre andet aftales og ved alle publikationer der udgår fra Enheden skal enheden nævnes.

Studenterprojekter der gennemføres med data fra enheden skal have mulighed for at få en af Forskningsenhedens  læger som vejleder, det samme gælder Ph.D-projekter o.l..

Projekterne skal godkendes i etisk komite og anmeldes til data tilsynet samt være godkendt af afdelingsledelsen samt Institut for Eksperimentel Klinisk Forskning ved kontraktforskning før start.

Publikationsreglerne er de internationalt gældende.